{"created":"2023-06-19T11:24:38.316231+00:00","id":5385,"links":{},"metadata":{"_buckets":{"deposit":"6ddb183e-e9db-4f5b-9a40-934442f80a3f"},"_deposit":{"created_by":3,"id":"5385","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"5385"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00005385","sets":["7","7:27:28"]},"author_link":["16922"],"item_6_alternative_title_3":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice"}]},"item_6_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographic_titles":[{"bibliographic_title":"学位論文内容の要旨及び審査結果の要旨"}]}]},"item_6_description_28":{"attribute_name":"識別番号 その他","attribute_value_mlt":[{"subitem_description":"Diabetologia 2016 Mar;59(3):533-41","subitem_description_type":"Other"},{"subitem_description":"PMID:26693710","subitem_description_type":"Other"}]},"item_6_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_6_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_6_relation_24":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s00125-015-3842-y","subitem_relation_type_select":"DOI"}}]},"item_6_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Yanagimachi, Tsuyoshi"}]},"item_6_version_type_38":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"柳町, 剛司"},{"creatorName":"ヤナギマチ, ツヨシ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"16922","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"6371.pdf","filesize":[{"value":"465.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"6371.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/5385/files/6371.pdf"},"version_id":"c618db3e-a910-4eeb-b72c-a05fbf8544c4"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"糖尿病で膵GIP（1-30）の発現は上昇し、PEG化したGIP（1-30）は低用量STZ誘発性糖尿病モデルマウスの高血糖の進展を抑制する","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"糖尿病で膵GIP（1-30）の発現は上昇し、PEG化したGIP（1-30）は低用量STZ誘発性糖尿病モデルマウスの高血糖の進展を抑制する","subitem_title_language":"ja"}]},"item_type_id":"6","owner":"3","path":["6","7","28"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2016-03-25"},"publish_date":"2016-03-25","publish_status":"0","recid":"5385","relation_version_is_last":true,"title":["糖尿病で膵GIP（1-30）の発現は上昇し、PEG化したGIP（1-30）は低用量STZ誘発性糖尿病モデルマウスの高血糖の進展を抑制する"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-04-10T02:05:34.104424+00:00"}